LL-28

N/A

Report date: 2025/01/26 15:47:55
NME

Base Information

Drug NameLL-28
Drug Alias Namedual IGF1R/Src inhibitor (Seoul National University)LL-28
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor I receptor antagonistsTyrosine-protein kinase SRC inhibitors
TargetsInsulin-like growth factor I receptorTyrosine-protein kinase SRC
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesSeoul National University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A